FIGURE 1.
Curve showing PFS (a) and OS (b) for all patients with extensive‐stage small‐cell lung cancer receiving carboplatin plus etoposide therapy (N = 63). OS, overall survival; PFS, progression‐free survival
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.